Australia's most trusted
source of pharma news
Posted 21 January 2022 PM
While the average price of branded pharmaceuticals in Australia is going backwards a global survey has found that in the United States, prices have soared by more than 18 per cent every year since 2017.
According to data analytics company GlobalData, the price of branded drugs in Australia fell by an annual average of 3.54 per cent between 2017-2021, a drop not as sharp as that experienced in some other developed nations.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.